Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.25%
1,104.10
+2.73
+0.25%
—1,101.371,103.631,105.311,091.41——
SIXC
Communications
SIXC
Communications
SIXC
-1.50%
604.16
-9.19
-1.50%
—613.35613.35613.35601.49——
SIXE
Energy
SIXE
Energy
SIXE
-0.09%
1,197.81
-1.02
-0.09%
—1,198.831,199.681,199.751,182.41——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,740.41
-15.54
-0.88%
—1,755.951,754.061,756.031,734.69——
SIXM
Financials
SIXM
Financials
SIXM
-0.64%
634.44
-4.07
-0.64%
—638.51637.41637.41633.05——
SIXR
Staples
SIXR
Staples
SIXR
-0.31%
840.90
-2.62
-0.31%
—843.52843.35846.40837.93——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.38%
215.13
-0.82
-0.38%
—215.95215.95216.84215.06——
SIXT
Technology
SIXT
Technology
SIXT
+2.86%
3,228.71
+89.80
+2.86%
—3,138.913,189.303,230.853,174.76——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.16%
935.87
+1.50
+0.16%
—934.37934.72938.26927.50——
SIXV
Health care
SIXV
Health care
SIXV
-1.37%
1,457.12
-20.31
-1.37%
—1,477.431,474.121,474.121,451.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.83%
2,399.84
+19.65
+0.83%
—2,380.192,389.342,403.042,380.47——
NVV1:FRA
Novavax Inc
€6.98
-0.29%
(-0.020) 1D
Apr 24, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NVV1...
Open
€6.98
High
€6.98
Low
€6.98
Mkt. cap
1.34B
Avg. vol.
1.96K
Volume
0.00
52-wk high
€10.03
52-wk low
€5.23
No. of employees
749
News stories
From sources across the web
Profile
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus, avian flu, shingles, Clostridioides difficile, and malaria. Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine. Wikipedia
About Novavax Inc
CEOJohn C. Jacobs
Employees749
Founded1987
HeadquartersGaithersburg, Maryland, United States
SectorBiotechnology
Websitenovavax.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
666.66M
239.24M
70.44M
147.14M
Cost of goods sold
103.05M
80.29M
103.70M
135.96M
Cost of revenue
103.05M
80.29M
103.70M
135.96M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.59M
53.28M
46.12M
-9.76M
Operating expense
47.59M
53.28M
46.12M
-9.76M
Total operating expenses
150.64M
133.57M
149.82M
126.20M
Operating income
516.01M
105.67M
-79.38M
20.94M
Other non operating income
17.86M
202.00K
178.00K
53.37M
EBT including unusual items
519.85M
107.45M
-203.04M
17.90M
EBT excluding unusual items
515.55M
112.05M
-75.68M
29.41M
Income tax expense
1.20M
946.00K
-657.00K
376.00K
Effective tax rate
0.23%
0.88%
0.32%
2.10%
Other operating expenses
-
-
-
-
Net income
518.65M
106.51M
-202.38M
17.53M
Net profit margin
77.80%
44.52%
-287.29%
11.91%
Earnings per share
2.93
0.62
-0.47
0.11
Interest and investment income
-
7.00M
7.20M
-
Interest expense
-5.72M
-5.52M
-5.48M
-27.99M
Net interest expenses
-5.72M
1.48M
1.72M
-27.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
524.35M
113.23M
-72.80M
26.06M
Gain or loss from assets sale
-
-
97.04M
807.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer